carvedilol has been researched along with Nephrosclerosis in 1 studies
Nephrosclerosis: Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We analyzed whether the use of a new beta adrenoceptor antagonist and vasodilator, carvedilol (CVD), slows the progression of nephrosclerosis and whether the renoprotective effect as well as reduction in cardiac hypertrophy is dependent on the degree of blood pressure reduction." | 7.69 | Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. ( Anabitarte, A; Cabrera, J; Llobet, J; Losada, A; Palop, L; Plaza, C; Rodriguez-Perez, JC, 1997) |
| " We analyzed whether the use of a new beta adrenoceptor antagonist and vasodilator, carvedilol (CVD), slows the progression of nephrosclerosis and whether the renoprotective effect as well as reduction in cardiac hypertrophy is dependent on the degree of blood pressure reduction." | 3.69 | Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. ( Anabitarte, A; Cabrera, J; Llobet, J; Losada, A; Palop, L; Plaza, C; Rodriguez-Perez, JC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodriguez-Perez, JC | 1 |
| Losada, A | 1 |
| Anabitarte, A | 1 |
| Cabrera, J | 1 |
| Llobet, J | 1 |
| Palop, L | 1 |
| Plaza, C | 1 |
1 other study available for carvedilol and Nephrosclerosis
| Article | Year |
|---|---|
Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Hypertrophy, Left Vent | 1997 |